Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;63(11):2486-2487.
doi: 10.1007/s00125-020-05216-2. Epub 2020 Jul 6.

Hyperglycaemia on admission to hospital and COVID-19

Celestino Sardu  1 , Nunzia D'Onofrio  2 , Maria Luisa Balestrieri  2 , Michelangela Barbieri  1 , Maria Rosaria Rizzo  1 , Vincenzo Messina  3 , Paolo Maggi  3 , Nicola Coppola  4 , Giuseppe Paolisso  1 , Raffaele Marfella  5
Affiliations
Comment

Hyperglycaemia on admission to hospital and COVID-19

Celestino Sardu et al. Diabetologia. 2020 Nov.
No abstract available

Keywords: Covid-19; Hyperglycaemia; Inflammatory cytokines; Mechanical ventilation; Non-invasive ventilation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(a) Blood glucose levels on admission to hospital and after 24 h for patients with (n = 60) and without severe disease (n = 72) at 20 days after hospitalisation. (b) Blood glucose changes between baseline and 24 h for patients with and without severe disease at 20 days after hospitalisation. Box-and-whisker plots display the median, 25th and 75th percentiles and range. *p < 0.05 by Student’s t test; all calculations were performed using SPSS version 23 software (IBM, Armonk, NY, USA)
See this image and copyright information in PMC

Comment in

  • Blood glucose levels and COVID-19. Reply to Sardu C, D'Onofrio N, Balestrieri ML et al [letter] and Lepper PM, Bals R, Jüni P et al [letter].
    Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B, Borot S, Bourgeon-Ghittori M, Bourron O, Boutoille D, Cazenave-Roblot F, Chaumeil C, Cosson E, Coudol S, Darmon P, Disse E, Ducet-Boiffard A, Gaborit B, Joubert M, Kerlan V, Laviolle B, Marchand L, Meyer L, Potier L, Prevost G, Riveline JP, Robert R, Saulnier PJ, Sultan A, Thébaut JF, Thivolet C, Tramunt B, Vatier C, Roussel R, Gautier JF, Gourdy P; CORONADO investigators. Cariou B, et al. Diabetologia. 2020 Nov;63(11):2491-2494. doi: 10.1007/s00125-020-05255-9. Epub 2020 Aug 20. Diabetologia. 2020. PMID: 32816095 Free PMC article. No abstract available.

Comment on

  • Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.
    Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B, Borot S, Bourgeon-Ghittori M, Bourron O, Boutoille D, Cazenave-Roblot F, Chaumeil C, Cosson E, Coudol S, Darmon P, Disse E, Ducet-Boiffard A, Gaborit B, Joubert M, Kerlan V, Laviolle B, Marchand L, Meyer L, Potier L, Prevost G, Riveline JP, Robert R, Saulnier PJ, Sultan A, Thébaut JF, Thivolet C, Tramunt B, Vatier C, Roussel R, Gautier JF, Gourdy P; CORONADO investigators. Cariou B, et al. Diabetologia. 2020 Aug;63(8):1500-1515. doi: 10.1007/s00125-020-05180-x. Epub 2020 May 29. Diabetologia. 2020. PMID: 32472191 Free PMC article.

References

    1. Cariou B, Hadjadj S, Wargny M et al (2020) Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 10.1007/s00125-020-05180-x - PMC - PubMed
    1. Li X, Xu S, Yu M et al (2020) Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 10.1016/j.jaci.2020.04.006 - PMC - PubMed
    1. Zhu L, She Z, Cheng X, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068–1077.e3. doi: 10.1016/j.cmet.2020.04.021. - DOI - PMC - PubMed
    1. Sardu C, D’Onofrio N, Balestrieri ML et al (2020) Outcomes in hyperglycemic patients affected by Covid-19: can we do more on glycemia control? Diabetes Care 43. 10.2337/DC20-0723 - PMC - PubMed
    1. Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q (2020) The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents. 10.1016/j.ijantimicag.2020.105954 - PMC - PubMed